Merck Sharp & Dohme initiates phase I study of MK-4250 in ART-naive patients with HIV-1 Jan. 29, 2018
FDA approves Isentress for the treatment of HIV-1 infection in newborns weighing at least 2 kg Dec. 4, 2017
ViiV initiates phase III study of long-acting cabotegravir for prevention of HIV infection in women Nov. 30, 2017
RSS